Related Experiment Video
Updated: Oct 4, 2025

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
Mechanical versus biological valve prostheses for left-sided infective endocarditis
Amila Kahrovic1, Philipp Angleitner1, Harald Herkner2
1Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Insights
For patients under 55 with left-sided infective endocarditis, mechanical valve replacement significantly reduces mortality and adverse events compared to biological valves. Further research is recommended to confirm these findings.
Area of Science:
- Cardiac Surgery
- Infective Endocarditis
- Prosthetic Heart Valves
Background:
- Left-sided infective endocarditis poses significant risks.
- Valve replacement is a critical intervention for these patients.
- The choice between mechanical and biological prostheses is debated.
Purpose of the Study:
- To compare outcomes of mechanical versus biological valve prostheses in patients with left-sided infective endocarditis.
- To identify patient subgroups that may benefit more from specific valve types.
Main Methods:
- Retrospective single-centre cohort study of 220 adult patients (2009-2018).
- Analysis of all-cause mortality, combined events (death, stroke, bleeding, reoperation), and re-endocarditis risk.
- Statistical analysis adjusted for relevant risk factors.
Main Results:
- Mechanical valve recipients were younger and had lower surgical risk scores.
- In patients <55 years, mechanical valves were associated with significantly lower all-cause mortality (aHR 0.35) and combined events (aHR 0.38).
- No increased re-endocarditis risk with mechanical valves; annular abscess increased re-endocarditis risk (aHR 3.06).
Conclusions:
- Mechanical valve implantation is associated with superior outcomes in patients <55 years with left-sided infective endocarditis.
- These findings suggest a potential benefit of mechanical valves in younger patients.
- A prospective randomized controlled trial is recommended for confirmation.
Objectives:
Our aim was to analyse outcomes after implantation of mechanical versus biological valve prostheses in patients presenting with left-sided infective endocarditis.
Methods:
We conducted a retrospective single-centre cohort study, analysing adults requiring valve surgery for left-sided infective endocarditis between January 2009 and December 2018 at the Department of Cardiac Surgery, Medical University of Vienna. The primary outcome variable was all-cause mortality. Secondary outcome variables included the occurrence of a combined event (death, stroke, intracerebral bleeding or reoperation) and the risk of re-endocarditis.
Results:
Among 220 patients, 76 (34.5%) underwent mechanical valve replacement, while 144 (65.5%) underwent biological valve replacement. Recipients of mechanical valve prostheses were younger at the time of surgery and presented with lower European System for Cardiac Operative Risk Evaluation II values. In patients <55 years of age, implantation of a mechanical valve prosthesis was independently associated with significantly lower risk of all-cause mortality (adjusted hazard ratio 0.35, 95% confidence interval 0.15-0.80, P = 0.013). Moreover, this group was at significantly lower risk of a combined event (adjusted hazard ratio 0.38, 95% confidence interval 0.19-0.76, P = 0.006). Implantation of a mechanical valve prosthesis was not associated with increased risk of re-endocarditis. The presence of an annular abscess significantly increased the risk of re-endocarditis (adjusted hazard ratio 3.06, 95% confidence interval 1.40-6.71, P = 0.005).
Conclusions:
In patients presenting with left-sided infective endocarditis <55 years of age, implantation of a mechanical valve prosthesis is associated with superior outcomes. A prospective randomized controlled trial is warranted to confirm these results.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management

